Daily non-political popular news in brief.

BRCA2 carriers at increased risk for deadly form of prostate cancer

Carriers of a BRCA2 variation specific to Iceland are more likely to develop aggressive and lethal prostate cancer than noncarriers, according to a study published online June 12 in the Journal of the National Cancer Institute.

Read more »

Keywords: brca2, carriers, increased, risk, deadly, form, prostate, cancer, carrier

« Previous | Next »

Similar news on "BRCA2 carriers at increased risk for deadly form of prostate cancer":

1. Analysis: Older men treated for early prostate cancer
   12-12-2006 · EurekAlert!
   An analysis of Surveillance, Epidemiology and End Results-Medicare records for 44,630 older men suggests surgery or radiation therapy for early-stage prostate cancer increased the lifespan of men between 65 and 80 years old compared to observation, sometimes known as "watch and wait." The study supported a benefit of treatment even for men whose disease had a low risk of spreading, and even if they were elderly men (75 to 80 years old).
   Similar news · Read more »
   
2. Men, don't skip your prostate cancer treatment appointments!
   10-30-2007 · EurekAlert!
   Men with 'low risk' prostate cancer who miss more than two radiation treatments in an eight week treatment face an increased chance of their cancer recurring. That is the conclusion of a new study examining more than 15 years of data and nearly 1,800 patients treated at Fox Chase Cancer Center in Philadelphia.
   Similar news · Read more »
   
3. Gene is associated with aggressive prostate cancer
   12-11-2007 · EurekAlert!
   A variant of a tumor suppressor gene may be associated with an increased risk of aggressive prostate cancer, according to a study published online Dec. 11 in the Journal of the National Cancer Institute.
   Similar news · Read more »
   
4. Analysis: Older men treated for early prostate cancer live longer than those not treated
   12-12-2006 · EurekAlert!
   An analysis of Surveillance, Epidemiology and End Results-Medicare records for 44,630 older men suggests surgery or radiation therapy for early-stage prostate cancer increased the lifespan of men between 65 and 80 years old compared to observation, sometimes known as "watch and wait." The study supported a benefit of treatment even for men whose disease had a low risk of spreading, and even if they were elderly men (75 to 80 years old).
   Similar news · Read more »
   
5. Breast cancer risk varies significantly among BRCA1 and BRCA2 carriers
   01-08-2008 · EurekAlert!
   There is a broad variation in the risk of developing breast cancer among people who carry the BRCA1 and BRCA2 gene mutation, according to a study in the Jan. 9/16 issue of JAMA.
   Similar news · Read more »
   
6. Excess weight and adult weight gain increase the risk of dying from prostate cancer
   01-08-2007 · EurekAlert!
   A new study finds that obesity increases the risk of death from prostate cancer, even though it does not increase the overall risk a man will be diagnosed with the disease. The study reveals that higher body mass index (BMI) and weight gain in adulthood correlated strongly with increased risk of death from prostate cancer.
   Similar news · Read more »
   
7. Breast cancer risk varies among women who are carriers of BRCA1 and BRCA2 gene mutations
   01-08-2008 · EurekAlert!
   Breast cancer risk varies widely among women who are carriers of the BRCA1 and BRCA2 mutations, according to a new study published in the Jan. 9, 2008, issue of the Journal of the American Medical Association.
   Similar news · Read more »
   
8. Soy found protective against localized prostate cancer
   03-15-2007 · EurekAlert!
   The largest study examining the relationship between the traditional soy-rich Japanese diet and development of prostate cancer in Japanese men has come to a seemingly contradictory conclusion: Intake of isoflavone chemicals, derived largely from soy foods, decreased the risk of localized prostate cancer but increased the risk of advanced prostate cancer.
   Similar news · Read more »
   
9. Benefit of cancer prevention surgery differs between women with BRCA1 and BRCA2 mutations
   02-11-2008 · EurekAlert!
   The surgical removal of the ovaries has been widely adopted as a cancer-risk-reducing strategy for women with either BRCA1 or BRCA2 mutations. A new multicenter study led by researchers at Memorial Sloan-Kettering Cancer Center is the first prospective examination of the impact of this procedure in which BRCA2 mutation carriers were analyzed separately from BRCA1 mutation carriers.
   Similar news · Read more »
   
10. No magic tomato? Study breaks link between lycopene and prostate cancer prevention
    05-17-2007 · EurekAlert!
    Tomatoes might be nutritious and tasty, but don't count on them to prevent prostate cancer. In the May issue of Cancer Epidemiology, Biomarkers & Prevention, researchers based at the National Cancer Institute and Fred Hutchinson Cancer Research Center report that lycopene, an antioxidant predominately found in tomatoes, does not effectively prevent prostate cancer. In fact, the researchers noted an association between beta-carotene, an antioxidant related to lycopene, and an increased risk for aggressive prostate cancer.
    Similar news · Read more »